Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | |
| Operating Expenses | 340 |
| Operating Income | -340 |
| Other Income | 14 |
| Pre-tax Income | -327 |
| Net Income Continuous | -327 |
| Net Income | $-327 |
| EPS Basic Total Ops | -61.64 |
| EPS Basic Continuous Ops | -61.64 |
| EPS Diluted Total Ops | -61.64 |
| EPS Diluted Continuous Ops | -61.64 |
| EBITDA(a) | $-340 |